Skip Navigation
Miami Transplant Institute

Miami Transplant Institute

Last Visited »

Basic Research

Research in the Miami Transplant Institute includes basic laboratory and clinical research within our three main divisions: Kidney and Pancreas, Liver and Gastrointestinal and Heart and Lungs transplant.

The overall mission of our research is to study novel immunosuppressive treatments in order for our transplanted patients to attain a better quality of live after transplantation: reducing the side effects of medications, as well as reducing the incidence of transplant rejection after cadaveric or living-related donor transplants.

Basic research is organized at the Heart and Lungs transplant program under the direction of Dr. Si Pham as well as at the Liver and GI transplant program under the direction of Dr. Rodrigo Vianna.

Our research is funded under different sources; institutional, government/agency and Industry.

BASIC RESEARCH

Our current research includes the following projects:

  • Effects of Aging and Bone Marrow Stem Cells on Neointimal Formation
    Sponsor: American Heart Association
    Sponsor Group: Agency
  • Cellular Therapeutics and Mechanisms of Vascular Dysfunction in Heart and Kidney Disease. Project leader of Project #3: Mechanisms Responsible for Exacerbated Neointimal Formation by Nicotine
    Sponsor: Florida Department of Health
    Sponsor Group: Agency
  • The Role of Nicotine in Smoking-Related Vascular Diseases
    Sponsor: Florida Department of Health
    Sponsor Group: Agency
    P.I: Roberto Vazquez-Padron, Ph.D.
  • The Effect of PIF (Pre-Implantation Factor) in Heterotopic Heart Transplant in Mice
    Sponsor: Institution
    Sponsor Group: Institutional
    P.I: Andreas Tzakis, M.D.
  • In Vivo Assessment of Intraportal T regulatory Cell Infusion in a Mouse Model
    Sponsor: Institution
    Sponsor Group: Institutional
    P.I: Andreas Tzakis, M.D.

Clinical Research

Clinical Research in the Miami Transplant Institute includes basic laboratory and clinical research within our three main divisions: Kidney and Pancreas, Liver and Gastrointestinal and Heart and Lungs transplant.

The overall mission of our research is to study novel immunosuppressive treatments in order for our transplanted patients to attain a better quality of live after transplantation: reducing the side effects of medications, as well as reducing the incidence of transplant rejection after cadaveric or living-related donor transplants.

Clinical trials are organized within the other two groups under the direction of Dr. George Burke for the Kidney and Pancreas Program and Dr. Andreas Tzakis for the Liver and GI program.

Our research is funded under different sources; institutional, government/agency and industry.

Miami Transplant Institute
ToolsFeedback